Evidence map›Paper›PMID 36289370›Full record

ArticleCommunications biology2022

An explainable model of host genetic interactions linked to COVID-19 severity.

Anthony Onoja, Nicola Picchiotti, Chiara Fallerini, Margherita Baldassarri, Francesca Fava, GEN-COVID Multicenter Study, Francesca Colombo, Francesca Chiaromonte, Alessandra Renieri, Simone Furini and 1 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 20 institutions in 3 countries.

Anthony OnojaLaboratorio di Biologia Bio@SNS, Scuola Normale Superiore, Pisa, Italy.
Nicola PicchiottiUniversity of Siena, DIISM-SAILAB, Siena, Italy.
Chiara FalleriniMed Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Margherita BaldassarriMed Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Francesca FavaMed Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
GEN-COVID Multicenter Study
Francesca ColomboIstituto di Tecnologie Biomediche-Consiglio Nazionale delle Ricerche, Segrate, MI, Italy.ORCID 0000-0003-2015-4317
Francesca ChiaromonteDept. of Statistics and Huck Institutes of the Life Sciences, Penn State University, University Park, PA, 16802, USA.
Alessandra RenieriMed Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy. alessandra.renieri@unisi.it.ORCID 0000-0002-0846-9220
Simone FuriniMed Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Francesco RaimondiLaboratorio di Biologia Bio@SNS, Scuola Normale Superiore, Pisa, Italy. francesco.raimondi@sns.it.ORCID 0000-0002-6891-3178
University of Siena · ITAzienda Usl Toscana Centro · ITOspedale San Donato · ITUniversity of Milan · ITOspedale Misericordia - Grosseto · ITAzienda Ospedaliera Universitaria Senese · ITCasa Sollievo della Sofferenza · ITIMT School for Advanced Studies Lucca · ITMeyer Children's Hospital · ITUniversity of Modena and Reggio Emilia · ITUniversity of Pisa · ITIstituti Clinici Scientifici Maugeri · ITPoliclinico San Matteo Fondazione · ITUniversity of L'Aquila · ITUniversity of Perugia · ITAgostino Gemelli University Polyclinic · ITCeinge Biotecnologie Avanzate (Italy) · ITCTO Hospital · ITIRCCS Istituto Auxologico Italiano · ITIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We employed a multifaceted computational strategy to identify the genetic factors contributing to increased risk of severe COVID-19 infection from a Whole Exome Sequencing (WES) dataset of a cohort of 2000 Italian patients. We coupled a stratified k-fold screening, to rank variants more associated with severity, with the training of multiple supervised classifiers, to predict severity based on screened features. Feature importance analysis from tree-based models allowed us to identify 16 variants with the highest support which, together with age and gender covariates, were found to be most predictive of COVID-19 severity. When tested on a follow-up cohort, our ensemble of models predicted severity with high accuracy (ACC = 81.88%; AUCROC = 96%; MCC = 61.55%). Our model recapitulated a vast literature of emerging molecular mechanisms and genetic factors linked to COVID-19 response and extends previous landmark Genome-Wide Association Studies (GWAS). It revealed a network of interplaying genetic signatures converging on established immune system and inflammatory processes linked to viral infection response. It also identified additional processes cross-talking with immune pathways, such as GPCR signaling, which might offer additional opportunities for therapeutic intervention and patient stratification. Publicly available PheWAS datasets revealed that several variants were significantly associated with phenotypic traits such as "Respiratory or thoracic disease", supporting their link with COVID-19 severity outcome.

Indexed as

COVID-19Exome SequencingGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPhenotype

Identifiers

PMID36289370
PMCPMC9606365
OpenAlexW4307564059

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.